BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26363059)

  • 1. The Cellular Localization of Human Cytomegalovirus Glycoprotein Expression Greatly Influences the Frequency and Functional Phenotype of Specific CD4+ T Cell Responses.
    Pachnio A; Zuo J; Ryan GB; Begum J; Moss PA
    J Immunol; 2015 Oct; 195(8):3803-15. PubMed ID: 26363059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.
    Ventura C; Bisceglia H; Girerd-Chambaz Y; Burdin N; Chaux P
    J Clin Immunol; 2012 Dec; 32(6):1305-16. PubMed ID: 22797815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.
    Freed DC; Tang Q; Tang A; Li F; He X; Huang Z; Meng W; Xia L; Finnefrock AC; Durr E; Espeseth AS; Casimiro DR; Zhang N; Shiver JW; Wang D; An Z; Fu TM
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4997-5005. PubMed ID: 24297878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
    Wussow F; Chiuppesi F; Martinez J; Campo J; Johnson E; Flechsig C; Newell M; Tran E; Ortiz J; La Rosa C; Herrmann A; Longmate J; Chakraborty R; Barry PA; Diamond DJ
    PLoS Pathog; 2014 Nov; 10(11):e1004524. PubMed ID: 25412505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
    Elkington R; Shoukry NH; Walker S; Crough T; Fazou C; Kaur A; Walker CM; Khanna R
    Eur J Immunol; 2004 Nov; 34(11):3216-26. PubMed ID: 15368271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization.
    Nelson CS; Jenks JA; Pardi N; Goodwin M; Roark H; Edwards W; McLellan JS; Pollara J; Weissman D; Permar SR
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary.
    Choi KY; McGregor A
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant Antiviral CD8
    Pardieck IN; van Duikeren S; Veerkamp DMB; Brasem DJ; Redeker A; van Bergen J; Han W; Ossendorp F; Zondag G; Arens R
    Front Immunol; 2022; 13():680559. PubMed ID: 35154089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes.
    Loughney JW; Rustandi RR; Wang D; Troutman MC; Dick LW; Li G; Liu Z; Li F; Freed DC; Price CE; Hoang VM; Culp TD; DePhillips PA; Fu TM; Ha S
    J Biol Chem; 2015 Jun; 290(26):15985-95. PubMed ID: 25947373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
    Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity.
    Kirchmeier M; Fluckiger AC; Soare C; Bozic J; Ontsouka B; Ahmed T; Diress A; Pereira L; Schödel F; Plotkin S; Dalba C; Klatzmann D; Anderson DE
    Clin Vaccine Immunol; 2014 Feb; 21(2):174-80. PubMed ID: 24334684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity.
    Cui X; Cao Z; Wang S; Flora M; Adler SP; McVoy MA; Snapper CM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
    Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus.
    Thomas M; Kropff B; Schneider A; Winkler TH; Görzer I; Sticht H; Britt WJ; Mach M; Reuter N
    J Virol; 2021 Aug; 95(18):e0065721. PubMed ID: 34160252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.
    Loomis RJ; Lilja AE; Monroe J; Balabanis KA; Brito LA; Palladino G; Franti M; Mandl CW; Barnett SW; Mason PW
    Vaccine; 2013 Jan; 31(6):919-26. PubMed ID: 23246547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
    Nelson CS; Huffman T; Jenks JA; Cisneros de la Rosa E; Xie G; Vandergrift N; Pass RF; Pollara J; Permar SR
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6267-6272. PubMed ID: 29712861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients.
    Marshall GS; Li M; Stout GG; Louthan MV; Duliège AM; Burke RL; Hunt LA
    Viral Immunol; 2000; 13(3):329-41. PubMed ID: 11016597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.
    Wen Y; Monroe J; Linton C; Archer J; Beard CW; Barnett SW; Palladino G; Mason PW; Carfi A; Lilja AE
    Vaccine; 2014 Jun; 32(30):3796-804. PubMed ID: 24837507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
    Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
    J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.